Sign inJoin waitlistJoin the waitlist

Aleksandar Videnovic

Director, Division of Sleep Medicine, Massachusetts General Hospital · Beth Israel Deaconess Medical Center

Credentials: · · · · · ·

History

Beth Israel Deaconess Medical Center
Present

Sleep Medicine
2007–2008
Rush University Medical Center
2006–2007
Neurology
Northwestern Memorial Hospital
2002–2005
Drexel University College of Medicine/Hahnemann University
2001–2002
University of Belgrade School of Medicine
1995–1998
MEDICINSKI FAKULTET, UNIVERZITETA U BEOGRADU, BEOGRAD
1990–1994

Research

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
Brain · 2019 · 887 citations
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
The Lancet Neurology · 2023 · 586 citations
Idiopathic REM sleep behaviour disorder and neurodegeneration - an update
Review · Nature Reviews Neurology · 2018 · Last of 3 authors · 412 citations

Tanya Simuni
16 papers
Erik St Louis
15 papers
Carlos Schenck
14 papers
Bradley Boeve
12 papers
LC
Lana Chahine
12 papers
Amy Amara
11 papers
Michael Howell
11 papers
DB
Donald Bliwise
10 papers
Yo-El Ju
10 papers
KM
Kenneth Marek
9 papers
Alon Avidan
8 papers
Miranda Lim
8 papers

Grants

A Consortium for Gut-Brain Communication in Parkinson's Disease- Supplement
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $2.1M · Columbia University Health Sciences
2024–2029
Retinal Determinants of Circadian Function and Sleep-Wake Cycles in Parkinson's Disease
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.9M · Massachusetts General Hospital
2023–2029
Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC)
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $12.2M · Massachusetts General Hospital
2023–2028
North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2)
National Institute on Aging · U19
Project lead · $1.3M · Washington University
2021–2027

Clinical trials

Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease
Principal investigator · Active not recruiting
Massachusetts General Hospital
2016–2026
Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease
Principal investigator · Completed
Massachusetts General Hospital
2012–2018
Light Therapy Treatment in Parkinson's Disease Patients With Daytime Somnolence
Principal investigator · Completed
Northwestern University
2007–2012
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
Study director · Terminated
Northwestern University
2008–2009